Presented at the 14th ISSX International Meeting, September 2025
Jingjing Yu, Sophie Argon, Katie Owens, Yan Wang, and Isabelle Ragueneau-Majlessi
Abstract
In the present work, drug metabolism, drug transport, and drug interaction in vitro, in silico, and clinical data for small molecular drugs approved by the U.S. Food and Drug Administration in 2024 (N = 34) were analyzed using Certara Drug Interaction Database (DIDB®; https://www.druginteractionsolutions.org/). The mechanism(s) and clinical relevance of these pharmacokinetic interactions were characterized based on information available in the new drug application reviews.